Stocks of vaccine makers plunged after President-elect Donald Trump selected vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Moderna, Novavax, BioNTech, and Pfizer shares all experienced significant drops in response to the news.